People

Mark Blumling

Mark Blumling is an executive in residence at Patient Square Capital. He founded and led clinical-research business Headlands Research and genomics company Genos, and co-founded Hyperion Therapeutics. He also advises Goldman Sachs Growth Equity and teaches at Stanford Law School.